Web(NASDAQ: ELOX) Eloxx Pharmaceuticals's current Earnings Per Share (EPS) is -$17.60. On average, analysts forecast that ELOX's EPS will be -$0.50 for 2024, with the lowest EPS forecast at -$0.53, and the highest EPS forecast at -$0.46. WebDec 23, 2024 · Stock Evaluator: Eloxx Pharmaceuticals Inc (ELOX) + Follow This Stock $2.04 -0.09 -4.23% December 23, 2024 3:42:33 PM EST Volume: 13,024 USD NASD DELAYED PRICE News & Events A+ Stock Grade Summary: COMPANY SUMMARY Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company.
Hedge Funds Have Never Been This Bullish On Eloxx ... - Yahoo!
WebApr 8, 2024 · According to analysts' consensus price target of $17.50, Eloxx Pharmaceuticals has a forecasted upside of 597.2% from its current price of $2.51. … WebOct 28, 2007 · The Company’s product candidates are derived from multiple key proprietary technology platforms: cell-based arrayed antibody discovery, ultralong antibody scaffolds … lockwood 110/40
4 ETFs with Eloxx Pharmaceuticals, Inc. (ELOX) exposure ETF.com
WebDec 23, 2024 · Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on ribosome modulation, by leveraging its TURBO-ZM … WebEloxx Pharmaceuticals, Inc. (ELOX) Latest Stock News & Headlines - Yahoo Finance U.S. markets closed Dow 30 Nasdaq (+0.76%) Russell 2000 (+0.13%) (-0.30%) Eloxx … WebGilad Shabtai Net Worth 2024 and insider trades. Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. Gilad Shabtai Net Worth 2024 and insider trades. Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. indigo airlines hyderabad office address